Posted by Michael Wonder on 05 May 2022
Your money or your life - the high cost of cancer drugs under Medicare Part D
4 May 2022 - The financial burden associated with orally administered anti-cancer drugs can be overwhelming for Medicare beneficiaries.
Policies adding an out of pocket spending cap to Part D have been proposed, and Congress could permit price negotiation for anti-cancer drugs.
